Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Reverse chamber remodelling following adrenergic-induced advanced cardiac dilatation and pump dysfunction.

Booysen HL, Norton GR, Opie LH, Woodiwiss AJ.

Basic Res Cardiol. 2012 Jan;107(1):238. doi: 10.1007/s00395-011-0238-0. Epub 2011 Dec 22.

PMID:
22189564
2.

Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.

Osadchii OE, Norton GR, McKechnie R, Deftereos D, Woodiwiss AJ.

Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1898-905. Epub 2006 Dec 8.

3.

Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats.

Osadchii OE, Woodiwiss AJ, Deftereos D, Norton GR.

Pflugers Arch. 2007 Nov;455(2):251-60. Epub 2007 Jun 9.

PMID:
17558518
4.

Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats.

Raymond AR, Hodson B, Woodiwiss AJ, Norton GR, Brooksbank RL.

Eur J Appl Physiol. 2013 Nov;113(11):2803-11. doi: 10.1007/s00421-013-2722-8. Epub 2013 Sep 6.

PMID:
24062009
5.

Impact of castration on changes in left ventricular diastolic pressure-volume relations induced by chronic adrenergic stimulation in rats.

Hodson B, Woodiwiss AJ, Norton GR, Michel FS.

J Cardiovasc Pharmacol. 2014 Jun;63(6):562-6. doi: 10.1097/FJC.0000000000000081.

PMID:
24477046
6.

Chronic beta-adrenoreceptor activation increases cardiac cavity size through chamber remodeling and not via modifications in myocardial material properties.

Gibbs M, Veliotes DG, Anamourlis C, Badenhorst D, Osadchii O, Norton GR, Woodiwiss AJ.

Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2762-7. Epub 2004 Aug 19.

7.

Myocardial structural, contractile and electrophysiological changes in the guinea-pig heart failure model induced by chronic sympathetic activation.

Soltysinska E, Olesen SP, Osadchii OE.

Exp Physiol. 2011 Jul;96(7):647-63. doi: 10.1113/expphysiol.2011.058503. Epub 2011 May 13.

8.

Susceptibility to systolic dysfunction in the myocardium from chronically infarcted spontaneously hypertensive rats.

Norton GR, Veliotes DG, Osadchii O, Woodiwiss AJ, Thomas DP.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H372-8. Epub 2007 Nov 9.

9.

Beta-adrenergic activation initiates chamber dilatation in concentric hypertrophy.

Badenhorst D, Veliotes D, Maseko M, Tsotetsi OJ, Brooksbank R, Naidoo A, Woodiwiss AJ, Norton GR.

Hypertension. 2003 Mar;41(3):499-504. Epub 2003 Feb 17.

10.

Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction.

Woodiwiss AJ, Tsotetsi OJ, Sprott S, Lancaster EJ, Mela T, Chung ES, Meyer TE, Norton GR.

Circulation. 2001 Jan 2;103(1):155-60.

11.

Rat strain-related differences in myocardial adrenergic tone and the impact on cardiac fibrosis, adrenergic responsiveness and myocardial structure and function.

Osadchii O, Norton G, Deftereos D, Woodiwiss A.

Pharmacol Res. 2007 Apr;55(4):287-94. Epub 2006 Dec 28.

PMID:
17257851
12.

In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure.

Guggilam A, Hutchinson KR, West TA, Kelly AP, Galantowicz ML, Davidoff AJ, Sadayappan S, Lucchesi PA.

J Mol Cell Cardiol. 2013 Apr;57:47-58. doi: 10.1016/j.yjmcc.2012.11.013. Epub 2012 Dec 7.

13.

Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation.

Veliotes DG, Woodiwiss AJ, Deftereos DA, Gray D, Osadchii O, Norton GR.

Hypertension. 2005 May;45(5):914-20. Epub 2005 Apr 18.

14.
15.

Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle.

Wang Z, Taylor LK, Denney WD, Hansen DE.

Circulation. 1994 Oct;90(4):2022-31.

PMID:
7522991
17.

Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats.

Veliotes DG, Norton GR, Correia RJ, Strijdom H, Badenhorst D, Brooksbank R, Woodiwiss AJ.

J Cardiovasc Pharmacol. 2010 Aug;56(2):203-11. doi: 10.1097/FJC.0b013e3181e92a01.

PMID:
20531215
18.

GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure.

Xu XB, Pang JJ, Cao JM, Ni C, Xu RK, Peng XZ, Yu XX, Guo S, Chen MC, Chen C.

Am J Physiol Heart Circ Physiol. 2005 Oct;289(4):H1643-51. Epub 2005 Jun 10.

20.

Distinct actions of intermittent and sustained β-adrenoceptor stimulation on cardiac remodeling.

Ma X, Song Y, Chen C, Fu Y, Shen Q, Li Z, Zhang Y.

Sci China Life Sci. 2011 Jun;54(6):493-501. doi: 10.1007/s11427-011-4183-9. Epub 2011 Jun 26.

PMID:
21706409
Items per page

Supplemental Content

Write to the Help Desk